SCHEMBL14416411

SCHEMBL14416411

Brc1ccc(-c2cc(-c3cc4ccccc4c4ccccc34)nc(-c3ccccc3)n2)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AGTR1 P30556 1/20 0.50
CYP1A1 P04798 2/20 0.49
CYP1A2 P05177 2/20 0.49
CYP1B1 Q16678 2/20 0.49
MEN1 O00255 5/20 0.49
KMT2A Q03164 5/20 0.49
ALDH1A1 P00352 4/20 0.49
MAPT P10636 4/20 0.49
HPGD P15428 3/20 0.49
NTSR1 P30989 1/20 0.49
MCL1 Q07820 2/20 0.43
KDM4E B2RXH2 2/20 0.43
LMNA P02545 1/20 0.43
GLA P06280 1/20 0.43
NR1H4 Q96RI1 1/20 0.43
ABCG2 Q9UNQ0 2/20 0.43
ADORA2A P29274 1/20 0.42
ADORA1 P30542 1/20 0.42
ACHE P22303 1/20 0.42
CYP11B1 P15538 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15502052 0.94 AGTR1 (0.50) AGTR1CYP1A1CYP1A2CYP1B1MEN1
SCHEMBL10051305 0.91 MEN1 (0.54) CYP1A1CYP1B1MEN1KMT2AALDH1A1
SCHEMBL10051206 0.91 MEN1 (0.54) CYP1A1CYP1B1MEN1KMT2AALDH1A1
SCHEMBL17932627 0.91 MEN1 (0.54) CYP1A1CYP1B1MEN1KMT2AALDH1A1
SCHEMBL19271374 0.91 MEN1 (0.53) AGTR1CYP1A2MEN1KMT2AALDH1A1
SCHEMBL18804087 0.88 MEN1 (0.49) CYP1A1CYP1A2CYP1B1MEN1KMT2A
SCHEMBL23594562 0.86 CYP1B1 (0.49) AGTR1CYP1A1CYP1A2CYP1B1MEN1
SCHEMBL19009513 0.86 MEN1 (0.56) CYP1A1CYP1B1MEN1KMT2AALDH1A1
SCHEMBL19383618 0.85 AGTR1 (0.50) AGTR1CYP1A1CYP1A2CYP1B1MEN1
SCHEMBL2754552 0.85 AGTR1 (0.50) AGTR1CYP1A1CYP1A2CYP1B1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230013934-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DIODE COMPRISING SAME LT MATERIALS CO., LTD. (KR) 2023-01-19 US disclosed
US-9523031-B2 Organic electroluminescent device IDEMITSU KOSAN CO., LTD. (JP) 2016-12-20 US disclosed
US-9523031-B2 Organic electroluminescent device IDEMITSU KOSAN CO., LTD. (JP) 2016-12-20 US disclosed
US-20070224448-A1 Organic Electroluminescent Device IDEMITSU KOSAN CO., LTD. (JP) 2007-09-27 US disclosed
US-20070224448-A1 Organic Electroluminescent Device IDEMITSU KOSAN CO., LTD. (JP) 2007-09-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230013934-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DIODE COMPRISING SAME CRY1, CYP1B1, CYP1A1 AGTR1 2586/4885CYP1A1 3/4885CYP1A2 5/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.